Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00223561
Status:
COMPLETED
Last Update Posted:
2006-03-01
First Post:
2005-09-13
Brief Title:
Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder
Sponsor:
Utrecht Institute for Pharmaceutical Sciences
Organization:
Utrecht Institute for Pharmaceutical Sciences
Study Overview
Official Title:
A Double Blind Placebo-Controlled Crossover Study to Determine the Effects of Methylphenidate on Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder
Status:
COMPLETED
Status Verified Date:
2006-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of this study is to determine the effects of methylphenidate versus placebo on driving ability of adult ADHD patients
Detailed Description:
This study was set-up to examine the controversial issue whether or not it is safe to drive a car or not when treated with methylphenidate
On-the-road driving tests during normal traffic are conducted to determine the effects of methylphenidate versus placebo on driving ability of adult ADHD patientsIn addition two laboratory tests are conducted to examine memory functioning and inhibitory control
On-the-road driving tests during normal traffic are conducted to determine the effects of methylphenidate versus placebo on driving ability of adult ADHD patientsIn addition two laboratory tests are conducted to examine memory functioning and inhibitory control
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None